Literature DB >> 10485346

Detection and typing of human papillomavirus DNA in paired urine and cervical scrapes.

S Strauss1, J Z Jordens, D McBride, C Sonnex, S Edwards, U Desselberger, P Watt, J J Gray.   

Abstract

The prevalence of human papillomavirus (HPV) in paired cervical scrape and urine specimens from 144 women attending a clinic for genitourinary medicine was determined by polymerase chain reaction (PCR) and nested PCR, using degenerate and general primer pairs localized within the L1 region. HPV typing was by restriction fragment length polymorphism (RFLP), type-specific PCR (HPV 6, 11, 16, 18, 33), and partial DNA sequencing of PCR products. HPV DNA was detected in 114 (84%) women. HPV DNA was detected in the specimens of 58 patients after amplification with MY09/MY11 primers and in a further 54 patients after nested PCR with the GP5+/GP6+ primers. A total of 106/136 (78%) of women had HPV DNA positive cervical scrapes and 89 (65%) had HPV DNA positive urine specimens. Both the urine and cervical specimens of 81 women were positive. In 25 women HPV DNA was detected in the cervical specimen only, and in 8 women HPV DNA was detected in the urine specimens only. A total of 108 specimens from 75 patients were typed. For 33 patients HPV typing was achieved in both the cervical and the urine specimens and 19 women had identical types in paired specimens. Multiple HPV infections could be detected in 15 (20%) of 75 women where either the cervical and urine specimen or both of the specimens could be typed. More then one HPV type was found in 8 specimens and from multiple sites (cervix and urinary tract) in the same patients on 7 occasions. The results of this study indicate that the detection of HPVs in the urogenital tract can be maximised through the testing of both cervical scrapes and urine specimens in conjunction with the use of a nested PCR to increase the sensitivity of HPV DNA detection. Also, urine cannot be a direct substitute for a cervical scrape as different HPV types are often detected in the urine compared with those detected in the cervix.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10485346     DOI: 10.1023/a:1007574231879

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  23 in total

1.  Rapid and simple method for purification of nucleic acids.

Authors:  R Boom; C J Sol; M M Salimans; C L Jansen; P M Wertheim-van Dillen; J van der Noordaa
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

2.  The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR.

Authors:  A M de Roda Husman; J M Walboomers; A J van den Brule; C J Meijer; P J Snijders
Journal:  J Gen Virol       Date:  1995-04       Impact factor: 3.891

3.  Colposcopy, punch biopsy, in situ DNA hybridization, and the polymerase chain reaction in searching for genital human papillomavirus (HPV) infections in women with normal PAP smears.

Authors:  S Syrjänen; J Saastamoinen; F J Chang; H X Ji; K Syrjänen
Journal:  J Med Virol       Date:  1990-08       Impact factor: 2.327

4.  Rapid detection of human papillomavirus in cervical scrapes by combined general primer-mediated and type-specific polymerase chain reaction.

Authors:  A J van den Brule; C J Meijer; V Bakels; P Kenemans; J M Walboomers
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

5.  Human papillomavirus infection in women infected with the human immunodeficiency virus.

Authors:  X W Sun; L Kuhn; T V Ellerbrock; M A Chiasson; T J Bush; T C Wright
Journal:  N Engl J Med       Date:  1997-11-06       Impact factor: 91.245

Review 6.  Papillomaviruses in anogenital cancer as a model to understand the role of viruses in human cancers.

Authors:  H zur Hausen
Journal:  Cancer Res       Date:  1989-09-01       Impact factor: 12.701

7.  Typing of human papillomaviruses by polymerase chain reaction amplification with L1 consensus primers and RFLP analysis.

Authors:  O Lungu; T C Wright; S Silverstein
Journal:  Mol Cell Probes       Date:  1992-04       Impact factor: 2.365

Review 8.  Human papillomaviruses in the pathogenesis of anogenital cancer.

Authors:  H zur Hausen
Journal:  Virology       Date:  1991-09       Impact factor: 3.616

9.  Prevalence of HPV in cytomorphologically normal cervical smears, as determined by the polymerase chain reaction, is age-dependent.

Authors:  P W Melkert; E Hopman; A J van den Brule; E K Risse; P J van Diest; O P Bleker; T Helmerhorst; M E Schipper; C J Meijer; J M Walboomers
Journal:  Int J Cancer       Date:  1993-04-01       Impact factor: 7.396

10.  Evaluation of the polymerase chain reaction for the detection of human papillomavirus from urine.

Authors:  J L Vossler; B A Forbes; M D Adelson
Journal:  J Med Virol       Date:  1995-03       Impact factor: 2.327

View more
  11 in total

Review 1.  Detection of human papillomavirus DNA in urine. A review of the literature.

Authors:  A Vorsters; I Micalessi; J Bilcke; M Ieven; J Bogers; P Van Damme
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-08-05       Impact factor: 3.267

Review 2.  Clinical applications of urinary cell-free DNA in cancer: current insights and promising future.

Authors:  Tian Lu; Jinming Li
Journal:  Am J Cancer Res       Date:  2017-11-01       Impact factor: 6.166

3.  Detection of human papillomavirus DNA in urine specimens from human immunodeficiency virus-positive women.

Authors:  Joeli A Brinkman; W Elizabeth Jones; Ann M Gaffga; Jonathan A Sanders; Anil K Chaturvedi; Joseph Slavinsky III; John L Clayton; Jeanne Dumestre; Michael E Hagensee
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

4.  Comparison of human papillomavirus detections in urine, vulvar, and cervical samples from women attending a colposcopy clinic.

Authors:  Vikrant V Sahasrabuddhe; Patti E Gravitt; S Terence Dunn; David Brown; Richard A Allen; Yolanda J Eby; Katie Smith; Rosemary E Zuna; Roy R Zhang; Michael A Gold; Mark Schiffman; Joan L Walker; Philip E Castle; Nicolas Wentzensen
Journal:  J Clin Microbiol       Date:  2013-11-06       Impact factor: 5.948

5.  Optimization of HPV DNA detection in urine by improving collection, storage, and extraction.

Authors:  A Vorsters; J Van den Bergh; I Micalessi; S Biesmans; J Bogers; A Hens; I De Coster; M Ieven; P Van Damme
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-06-12       Impact factor: 3.267

Review 6.  Accuracy of urinary human papillomavirus testing for presence of cervical HPV: systematic review and meta-analysis.

Authors:  Neha Pathak; Julie Dodds; Javier Zamora; Khalid Khan
Journal:  BMJ       Date:  2014-09-16

7.  High-risk and multiple human papillomavirus (HPV) infections in cancer-free Jamaican women.

Authors:  Angela Watt; David Garwood; Maria Jackson; Novie Younger; Camille Ragin; Monica Smikle; Horace Fletcher; Norma McFarlane-Anderson
Journal:  Infect Agent Cancer       Date:  2009-02-10       Impact factor: 2.965

8.  HPV-Based Screening, Triage, Treatment, and Followup Strategies in the Management of Cervical Intraepithelial Neoplasia.

Authors:  Oscar Peralta-Zaragoza; Jessica Deas; Claudia Gómez-Cerón; Wendy Argelia García-Suastegui; Geny Del Socorro Fierros-Zárate; Nadia Judith Jacobo-Herrera
Journal:  Obstet Gynecol Int       Date:  2013-04-14

9.  Monitoring human papillomavirus prevalence in urine samples: a review.

Authors:  Espen Enerly; Cecilia Olofsson; Mari Nygård
Journal:  Clin Epidemiol       Date:  2013-03-12       Impact factor: 4.790

10.  Genomic imbalances in 70 snap-frozen cervical squamous intraepithelial lesions: associations with lesion grade, state of the HPV16 E2 gene and clinical outcome.

Authors:  W Alazawi; M Pett; S Strauss; R Moseley; J Gray; M Stanley; N Coleman
Journal:  Br J Cancer       Date:  2004-12-13       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.